Búsqueda | Biblioteca Virtual en Salud Fronteriza

1.

Mesothelioma: Pleural, Version 1.2024.

Stevenson, James; Ettinger, David S; Wood, Douglas E; Aisner, Dara L; Akerley, Wallace; Bauman, Jessica R; Bharat, Ankit; Bruno, Debora S; Chang, Joe Y; Chirieac, Lucian R; DeCamp, Malcolm; Desai, Aakash; Dilling, Thomas J; Dowell, Jonathan; Durm, Gregory A; Garassino, Marina C; Gettinger, Scott; Grotz, Travis E; Gubens, Matthew A; Lackner, Rudy P; Lanuti, Michael; Lin, Jules; Loo, Billy W; Lovly, Christine M; Maldonado, Fabien; Massarelli, Erminia; Morgensztern, Daniel; Mullikin, Trey C; Ng, Thomas; Otterson, Gregory A; Owen, Dawn; Patel, Sandip P; Patil, Tejas; Polanco, Patricio M; Riely, Gregory J; Riess, Jonathan; Shapiro, Theresa A; Singh, Aditi P; Tam, Alda; Tanvetyanon, Tawee; Yanagawa, Jane; Yang, Stephen C; Yau, Edwin; Gregory, Kristina; Hang, Lisa.

J Natl Compr Canc Netw ; 22(2): 72-81, 2024 03.

Artículo en Inglés | MEDLINE | ID: mdl-38503043

2.

Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations.

Paik, Paul K; Felip, Enriqueta; Veillon, Remi; Sakai, Hiroshi; Cortot, Alexis B; Garassino, Marina C; Mazieres, Julien; Viteri, Santiago; Senellart, Helene; Van Meerbeeck, Jan; Raskin, Jo; Reinmuth, Niels; Conte, Pierfranco; Kowalski, Dariusz; Cho, Byoung Chul; Patel, Jyoti D; Horn, Leora; Griesinger, Frank; Han, Ji-Youn; Kim, Young-Chul; Chang, Gee-Chen; Tsai, Chen-Liang; Yang, James C-H; Chen, Yuh-Min; Smit, Egbert F; van der Wekken, Anthonie J; Kato, Terufumi; Juraeva, Dilafruz; Stroh, Christopher; Bruns, Rolf; Straub, Josef; Johne, Andreas; Scheele, Jürgen; Heymach, John V; Le, Xiuning.

N Engl J Med ; 383(10): 931-943, 2020 09 03.

Artículo en Inglés | MEDLINE | ID: mdl-32469185

3.

Targeted Toxicities: Protocols for Monitoring the Adverse Events of Targeted Therapies Used in the Treatment of Non-Small Cell Lung Cancer.

Hines, Jacobi B; Bowar, Benjamin; Levine, Emma; Esposito, Alessandra; Garassino, Marina C; Bestvina, Christine M.

Int J Mol Sci ; 24(11)2023 May 29.

Artículo en Inglés | MEDLINE | ID: mdl-37298380

4.

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.

Gandhi, Leena; Rodríguez-Abreu, Delvys; Gadgeel, Shirish; Esteban, Emilio; Felip, Enriqueta; De Angelis, Flávia; Domine, Manuel; Clingan, Philip; Hochmair, Maximilian J; Powell, Steven F; Cheng, Susanna Y-S; Bischoff, Helge G; Peled, Nir; Grossi, Francesco; Jennens, Ross R; Reck, Martin; Hui, Rina; Garon, Edward B; Boyer, Michael; Rubio-Viqueira, Belén; Novello, Silvia; Kurata, Takayasu; Gray, Jhanelle E; Vida, John; Wei, Ziwen; Yang, Jing; Raftopoulos, Harry; Pietanza, M Catherine; Garassino, Marina C.

N Engl J Med ; 378(22): 2078-2092, 2018 May 31.

Artículo en Inglés | MEDLINE | ID: mdl-29658856

5.

Patient-reported outcomes with durvalumab by PD-L1 expression and prior chemoradiotherapy-related variables in unresectable stage III non-small-cell lung cancer.

Garassino, Marina C; Paz-Ares, Luis; Hui, Rina; Faivre-Finn, Corinne; Spira, Alex; Planchard, David; Özgüroglu, Mustafa; Daniel, Davey; Vicente, David; Murakami, Shuji; Langer, Corey; Senan, Suresh; Spigel, David; Rydén, Anna; Zhang, Yiduo; O'Brien, Cathy; Dennis, Phillip A; Antonia, Scott J.

Future Oncol ; 17(10): 1165-1184, 2021 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-33583206

6.

Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.

Garassino, Marina C; Gadgeel, Shirish; Esteban, Emilio; Felip, Enriqueta; Speranza, Giovanna; Domine, Manuel; Hochmair, Maximilian J; Powell, Steven; Cheng, Susanna Yee-Shan; Bischoff, Helge G; Peled, Nir; Reck, Martin; Hui, Rina; Garon, Edward B; Boyer, Michael; Wei, Ziwen; Burke, Thomas; Pietanza, M Catherine; Rodríguez-Abreu, Delvys.

Lancet Oncol ; 21(3): 387-397, 2020 03.

Artículo en Inglés | MEDLINE | ID: mdl-32035514

7.

Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non-small cell lung cancer without tumor PD-L1 expression: A pooled analysis of 3 randomized controlled trials.

Borghaei, Hossein; Langer, Corey J; Paz-Ares, Luis; Rodríguez-Abreu, Delvys; Halmos, Balazs; Garassino, Marina C; Houghton, Baerin; Kurata, Takayasu; Cheng, Ying; Lin, Jianxin; Pietanza, M Catherine; Piperdi, Bilal; Gadgeel, Shirish M.

Cancer ; 126(22): 4867-4877, 2020 11 15.

Artículo en Inglés | MEDLINE | ID: mdl-32914866

8.

Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.

Mok, Tony S; Wu, Yi-Long; Ahn, Myung-Ju; Garassino, Marina C; Kim, Hye R; Ramalingam, Suresh S; Shepherd, Frances A; He, Yong; Akamatsu, Hiroaki; Theelen, Willemijn S M E; Lee, Chee K; Sebastian, Martin; Templeton, Alison; Mann, Helen; Marotti, Marcelo; Ghiorghiu, Serban; Papadimitrakopoulou, Vassiliki A.

N Engl J Med ; 376(7): 629-640, 2017 02 16.

Artículo en Inglés | MEDLINE | ID: mdl-27959700

9.

Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab.

Friedlaender, Alex; Metro, Giulio; Signorelli, Diego; Gili, Alessio; Economopoulou, Panagiota; Roila, Fausto; Banna, Giuseppe; De Toma, Alessandro; Camerini, Andrea; Christopoulou, Athina; Lo Russo, Giuseppe; Banini, Marco; Galetta, Domenico; Jimenez, Beatriz; Collazo-Lorduy, Ana; Calles, Antonio; Baxevanos, Panagiotis; Linardou, Helena; Kosmidis, Paris; Mountzios, Giannis; Garassino, Marina C; Addeo, Alfredo.

Acta Oncol ; 59(9): 1058-1063, 2020 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-32762415

10.

Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy.

Galli, Giulia; Proto, Claudia; Signorelli, Diego; Imbimbo, Martina; Ferrara, Roberto; Prelaj, Arsela; De Toma, Alessandro; Ganzinelli, Monica; Zilembo, Nicoletta; de Braud, Filippo; Garassino, Marina C; Lo Russo, Giuseppe.

Future Oncol ; 15(23): 2743-2757, 2019 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-31339060

11.

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.

Brahmer, Julie; Reckamp, Karen L; Baas, Paul; Crinò, Lucio; Eberhardt, Wilfried E E; Poddubskaya, Elena; Antonia, Scott; Pluzanski, Adam; Vokes, Everett E; Holgado, Esther; Waterhouse, David; Ready, Neal; Gainor, Justin; Arén Frontera, Osvaldo; Havel, Libor; Steins, Martin; Garassino, Marina C; Aerts, Joachim G; Domine, Manuel; Paz-Ares, Luis; Reck, Martin; Baudelet, Christine; Harbison, Christopher T; Lestini, Brian; Spigel, David R.

N Engl J Med ; 373(2): 123-35, 2015 Jul 09.

Artículo en Inglés | MEDLINE | ID: mdl-26028407

12.

Pembrolizumab plus Chemotherapy in Lung Cancer.

Gandhi, Leena; Garassino, Marina C.

N Engl J Med ; 379(11): e18, 2018 09 13.

Artículo en Inglés | MEDLINE | ID: mdl-30207917

13.

Pembrolizumab Plus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After 5 Years of Follow-Up.

Gadgeel, Shirish M; Rodríguez-Abreu, Delvys; Halmos, Balazs; Garassino, Marina C; Kurata, Takayasu; Cheng, Ying; Jensen, Erin; Shamoun, Mark; Rajagopalan, Kumar; Paz-Ares, Luis.

J Thorac Oncol ; 2024 Apr 18.

Artículo en Inglés | MEDLINE | ID: mdl-38642841

14.

Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC.

Hines, Jacobi B; Cameron, Robert B; Esposito, Alessandra; Kim, Leeseul; Porcu, Luca; Nuccio, Antonio; Viscardi, Giuseppe; Ferrara, Roberto; Veronesi, Giulia; Forde, Patrick M; Taube, Janis; Vokes, Everett; Bestvina, Christine M; Dolezal, James M; Sacco, Matteo; Monteforte, Marta; Cascone, Tina; Garassino, Marina C; Torri, Valter.

J Thorac Oncol ; 2024 Mar 08.

Artículo en Inglés | MEDLINE | ID: mdl-38461929

15.

Prevention of chemotherapy-induced nausea and vomiting and the role of neurokinin 1 inhibitors: from guidelines to clinical practice in solid tumors.

Di Maio, Massimo; Bria, Emilio; Banna, Giuseppe L; Puglisi, Fabio; Garassino, Marina C; Lorusso, Domenica; Perrone, Francesco.

Anticancer Drugs ; 24(2): 99-111, 2013 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-23165435

16.

Real-World Treatment Patterns and Outcomes of First-Line Immunotherapy Among Patients With Advanced Nonsquamous NSCLC Harboring BRAF, MET, or HER2 Alterations.

Garassino, Marina C; Oskar, Sabine; Arunachalam, Ashwini; Zu, Ke; Kao, Yu-Han; Chen, Cai; Meng, Weilin; Pietanza, M Catherine; Zhao, Bin; Aggarwal, Himani.

JTO Clin Res Rep ; 4(10): 100568, 2023 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-37744307

17.

What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?

Cameron, Robert B; Hines, Jacobi B; Torri, Valter; Porcu, Luca; Donington, Jessica; Bestvina, Christine M; Vokes, Everett; Dolezal, James M; Esposito, Alessandra; Garassino, Marina C.

Ther Adv Med Oncol ; 15: 17588359231198446, 2023.

Artículo en Inglés | MEDLINE | ID: mdl-37720499

18.

Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC.

Garassino, Marina C; Gadgeel, Shirish; Novello, Silvia; Halmos, Balazs; Felip, Enriqueta; Speranza, Giovanna; Hui, Rina; Garon, Edward B; Horinouchi, Hidehito; Sugawara, Shunichi; Rodriguez-Abreu, Delvys; Reck, Martin; Cristescu, Razvan; Aurora-Garg, Deepti; Loboda, Andrey; Lunceford, Jared; Kobie, Julie; Ayers, Mark; Piperdi, Bilal; Pietanza, M Catherine; Paz-Ares, Luis.

JTO Clin Res Rep ; 4(1): 100431, 2023 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-36793385

19.

Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-Label, Phase 2 Trial (Cohort 4).

Cornelissen, Robin; Prelaj, Arsela; Sun, Sophie; Baik, Christina; Wollner, Mirjana; Haura, Eric B; Mamdani, Hirva; Riess, Jonathan W; Cappuzzo, Federico; Garassino, Marina C; Heymach, John V; Socinski, Mark A; Leu, Szu-Yun; Bhat, Gajanan; Lebel, Francois; Le, Xiuning.

J Thorac Oncol ; 18(8): 1031-1041, 2023 08.

Artículo en Inglés | MEDLINE | ID: mdl-36958688

20.

Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study.

Girard, Nicolas; Bar, Jair; Garrido, Pilar; Garassino, Marina C; McDonald, Fiona; Mornex, Françoise; Filippi, Andrea R; Smit, Hans J M; Peters, Solange; Field, John K; Christoph, Daniel C; Sibille, Anne; Fietkau, Rainer; Haakensen, Vilde D; Chouaid, Christos; Markman, Ben; Hiltermann, T Jeroen N; Taus, Alvaro; Sawyer, William; Allen, Allison; Chander, Pratibha; Licour, Muriel; Solomon, Benjamin.

J Thorac Oncol ; 18(2): 181-193, 2023 02.

Artículo en Inglés | MEDLINE | ID: mdl-36307040

Biblioteca Virtual en Salud Fronteriza

México - Estados Unidos

Su selección (0)

Formato de exportación:

Exportar: